Literature DB >> 9489967

Effect of mitral regurgitation on left ventricular thrombus formation in dilated cardiomyopathy.

V G Kalaria1, M R Passannante, T Shah, K Modi, A B Weisse.   

Abstract

To assess whether the presence of mitral regurgitation has a protective effect on left ventricular thrombus formation in a heterogeneous group of patients with dilated cardiomyopathy, a group of 103 patients with dilated cardiomyopathy identified by means of echocardiographic criteria was assembled over 1 year. The purpose of the study was to define a subgroup of patients with dilated cardiomyopathy from whom long-term anticoagulation might be withheld. Each echocardiogram was evaluated for the presence of left ventricular thrombus, presence and severity of mitral regurgitation, and ejection fraction. The role of clinical factors and clotting factors in left ventricular thrombus formation was assessed. Left ventricular thrombus was not present in 91 patients (group A) and was present in 12 patients (group B). Group B had larger left atrial and left ventricular systolic dimensions and decreased left ventricular systolic function. Mitral regurgitation jet area and ratio between mitral regurgitation jet area and left atrial area were lower (signifying less severe mitral regurgitation) among patients in group B. Although mitral regurgitation was equally present in group A and group B, severe mitral regurgitation was found only in group A patients ( 11 of 91 patients). Among patients with dilated cardiomyopathy, left ventricular ejection fraction is the factor most associated with left ventricular thrombus formation. The presence of severe mitral regurgitation may have a protective role in left ventricular thrombus formation.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9489967     DOI: 10.1016/s0002-8703(98)70084-5

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  18 in total

1.  Presentation, management and outcomes of thrombosis for children with cardiomyopathy.

Authors:  Brian W McCrindle; Tara Karamlou; Harvey Wong; Nirupama Gangam; Kalyani R Trivedi; Kyong-Jin Lee; Lee N Benson
Journal:  Can J Cardiol       Date:  2006-06       Impact factor: 5.223

2.  Warfarin and aspirin in patients with heart failure and sinus rhythm.

Authors:  Shunichi Homma; John L P Thompson; Patrick M Pullicino; Bruce Levin; Ronald S Freudenberger; John R Teerlink; Susan E Ammon; Susan Graham; Ralph L Sacco; Douglas L Mann; J P Mohr; Barry M Massie; Arthur J Labovitz; Stefan D Anker; Dirk J Lok; Piotr Ponikowski; Conrado J Estol; Gregory Y H Lip; Marco R Di Tullio; Alexandra R Sanford; Vilma Mejia; Andre P Gabriel; Mirna L del Valle; Richard Buchsbaum
Journal:  N Engl J Med       Date:  2012-05-02       Impact factor: 91.245

3.  Bleeding Risk and Antithrombotic Strategy in Patients With Sinus Rhythm and Heart Failure With Reduced Ejection Fraction Treated With Warfarin or Aspirin.

Authors:  Siqin Ye; Bin Cheng; Gregory Y H Lip; Richard Buchsbaum; Ralph L Sacco; Bruce Levin; Marco R Di Tullio; Min Qian; Douglas L Mann; Patrick M Pullicino; Ronald S Freudenberger; John R Teerlink; J P Mohr; Susan Graham; Arthur J Labovitz; Conrado J Estol; Dirk J Lok; Piotr Ponikowski; Stefan D Anker; John L P Thompson; Shunichi Homma
Journal:  Am J Cardiol       Date:  2015-06-24       Impact factor: 2.778

4.  Effects of congestive heart failure on plasma von Willebrand factor and soluble P-selectin concentrations in patients with non-valvar atrial fibrillation.

Authors:  G Y H Lip; L A Pearce; B S P Chin; D S G Conway; R G Hart
Journal:  Heart       Date:  2005-06       Impact factor: 5.994

5.  Resting Heart Rate and Ischemic Stroke in Patients with Heart Failure.

Authors:  Koki Nakanishi; Marco R Di Tullio; Min Qian; John L P Thompson; Arthur J Labovitz; Douglas L Mann; Ralph L Sacco; Patrick M Pullicino; Ronald S Freudenberger; John R Teerlink; Susan Graham; Gregory Y H Lip; Bruce Levin; Jay P Mohr; Richard Buchsbaum; Conrado J Estol; Dirk J Lok; Piotr Ponikowski; Stefan D Anker; Shunichi Homma
Journal:  Cerebrovasc Dis       Date:  2017-04-19       Impact factor: 2.762

6.  CHA2 DS2 -VASc score and adverse outcomes in patients with heart failure with reduced ejection fraction and sinus rhythm.

Authors:  Siqin Ye; Min Qian; Bo Zhao; Richard Buchsbaum; Ralph L Sacco; Bruce Levin; Marco R Di Tullio; Douglas L Mann; Patrick M Pullicino; Ronald S Freudenberger; John R Teerlink; J P Mohr; Susan Graham; Arthur J Labovitz; Conrado J Estol; Dirk J Lok; Piotr Ponikowski; Stefan D Anker; Gregory Y H Lip; John L P Thompson; Shunichi Homma
Journal:  Eur J Heart Fail       Date:  2016-07-21       Impact factor: 15.534

7.  A single-center experience with intracardiac thrombosis in children with dilated cardiomyopathy.

Authors:  Soo-Han Choi; Soo In Jeong; Ji-Hyuk Yang; I-Seok Kang; Tae-Gook Jun; Heung-Jae Lee; June Huh
Journal:  Pediatr Cardiol       Date:  2010-02       Impact factor: 1.655

8.  Relation between early mitral regurgitation and left ventricular thrombus formation after acute myocardial infarction: results of the GISSI-3 echo substudy.

Authors:  L Ascione; F Antonini-Canterin; F Macor; E Cervesato; F Chiarella; P Giannuzzi; P L Temporelli; F Gentile; D Lucci; A P Maggioni; L Tavazzi; L Badano; I Stoian; R Piazza; E Bosimini; D Pavan; G L Nicolosi
Journal:  Heart       Date:  2002-08       Impact factor: 5.994

9.  Evaluation of percutaneous annuloplasty for treatment of functional mitral regurgitation: A retrospective study.

Authors:  Suat Görmel; Salim Yaşar; Serkan Asil; Erkan Yıldırım; Serdar Fırtına; Hatice Taşkan; Mustafa Köklü; Yalçın Gökoğlan; Barış Buğan; Ayse Saatçi Yaşar; Hasan Kutsi Kabul; Murat Çelik; Uygar Çağdaş Yüksel; Cem Barçın
Journal:  Anatol J Cardiol       Date:  2021-07       Impact factor: 1.596

Review 10.  Role of cardiac and extracranial vascular CT in the evaluation/management of cerebral ischemia and stroke.

Authors:  Shahmir Kamalian; Shervin Kamalian; Stuart R Pomerantz; Teerath P Tanpitukpongse; Rajiv Gupta; Javier M Romero; Douglas S Katz
Journal:  Emerg Radiol       Date:  2013-03-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.